A carregar...
Production of recombinant coagulation factors: Are humans the best host cells?
The main treatment option for Hemophilia A/B patients involves the administration of recombinant coagulation factors on-demand or in a prophylactic approach. Despite the safety and efficacy of this replacement therapy, the development of antibodies against the coagulation factor infused, which neutr...
Na minha lista:
| Publicado no: | Bioengineered |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5639856/ https://ncbi.nlm.nih.gov/pubmed/28277160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21655979.2017.1279767 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|